| 摘要 |
A pharmaceutical composition comprising a PD-1 inhibitor and a Hsp90 inhibitor, or a tautomer, or a pharmaceutically acceptable salt thereof, wherein the Hsp90 inhibitor is 3- (2,4-dihydroxy-5-isopropyl-phenyl)-4-(l-methyl-indol-5-yl)-5-hydroxy-[l,2,4] triazole or 5- hydroxy-4-(5-hydroxy-4-(l-methyl-lH-indol-5-yl)-4H-l,2,4-triazol-3-yl)-2-isopropylphenyl dihydrogen phosphate. Also provided is a method for treating cancer in a subject in need thereof, using the pharmaceutical composition described herein. |
